Literature DB >> 2853165

Essential fatty acids prevent slowed nerve conduction in streptozotocin diabetic rats.

P O Julu1.   

Abstract

Rats were given streptozotocin to induce insulin-dependent diabetes or citrate buffer alone in two experiments. Initially, the effect of 5 wks of dietary gamma-linolenic acid (GLA) plus eicosapentaenoic acid (EPA) on cutaneous nerve conduction velocity (CV) was examined. CV was determined by direct stimulation and recording from saphenous nerve under urethane anesthesia. Secondly, a 5 weeks study of supplementing the diet with GLA, GLA and EPA, or hydrogenated coconut oil (HC) was done. In addition, motor nerve CV was determined by directly stimulating sciatic nerve and recording from gastrocnemius muscle. The acute diabetes led to weight loss, and elevated blood glucose and glycosylated hemoglobin levels. Essential fatty acid (EFA) supplementation had no effect on any of these measures of severity of diabetes. In diabetic rats without EFA supplementation, CV of the myelinated fibers fell by 19-21%, while those receiving both GLA and EPA had normal CV. In diabetic rats receiving GLA alone, CV fell by 5-7%, which was significantly less than those without EFA supplementation (p less than 0.01 for cutaneous, and p less than 0.001 for motor nerves).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2853165     DOI: 10.1016/s0891-6632(88)80006-0

Source DB:  PubMed          Journal:  J Diabet Complications        ISSN: 0891-6632


  12 in total

1.  Comparison of the effects of ascorbyl gamma-linolenic acid and gamma-linolenic acid in the correction of neurovascular deficits in diabetic rats.

Authors:  N E Cameron; M A Cotter
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

2.  Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost.

Authors:  M A Cotter; K C Dines; N E Cameron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

Review 3.  The Potential Role of Fatty Acids in Treating Diabetic Neuropathy.

Authors:  Mark A Yorek
Journal:  Curr Diab Rep       Date:  2018-08-25       Impact factor: 4.810

4.  The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen.

Authors:  N E Cameron; M A Cotter; K C Dines; S Robertson; D Cox
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

5.  Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats.

Authors:  K C Dines; M A Cotter; N E Cameron
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

6.  Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus.

Authors:  E J Stevens; M J Lockett; A L Carrington; D R Tomlinson
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

7.  Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas.

Authors:  K J Hardy; J Lipton; M O Scase; D H Foster; J H Scarpello
Journal:  Br J Ophthalmol       Date:  1992-08       Impact factor: 4.638

8.  Nonesterified fatty acids in normal and diabetic rat sciatic nerve.

Authors:  J Chattopadhyay; E W Thompson; H H Schmid
Journal:  Lipids       Date:  1992-07       Impact factor: 1.880

9.  The effects of dietary treatment with essential fatty acids on sciatic nerve conduction and activity of the Na+/K+ pump in streptozotocin-diabetic rats.

Authors:  M J Lockett; D R Tomlinson
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

10.  Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats.

Authors:  N E Cameron; M A Cotter; T C Hohman
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.